美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
62135-122-30	62135-122	HUMAN PRESCRIPTION DRUG	Ondansetron	Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20220330	N/A	ANDA	ANDA077406	Chartwell RX, LLC	ONDANSETRON	8 mg/1	30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62135-122-30)
62135-121-30	62135-121	HUMAN PRESCRIPTION DRUG	Ondansetron	Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20220330	N/A	ANDA	ANDA077406	Chartwell RX, LLC	ONDANSETRON	4 mg/1	30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62135-121-30)
62135-878-30	62135-878	HUMAN PRESCRIPTION DRUG	Ondansetron	Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20240620	N/A	ANDA	ANDA077406	Chartwell RX, LLC	ONDANSETRON	16 mg/1	30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62135-878-30)
62135-879-30	62135-879	HUMAN PRESCRIPTION DRUG	Ondansetron	Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20240620	N/A	ANDA	ANDA077406	Chartwell RX, LLC	ONDANSETRON	24 mg/1	30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62135-879-30)
72336-073-30	72336-073	HUMAN PRESCRIPTION DRUG	Ondansetron	Ondansetron	TABLET, ORALLY DISINTEGRATING	ORAL	20240620	N/A	ANDA	ANDA077406	Lifsa Drugs LLC	ONDANSETRON	16 mg/1	30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (72336-073-30)